Allergan Acquired Medical Aesthetics Company

| By | Aesthetic, Allergan, M&A

Allergan plc, a leading global pharmaceutical company, announced it has completed the acquisition of Envy Medical, Inc., a privately held company with proprietary technology in skin resurfacing. The acquisition enhances Allergan’s best-in-class Medical Aesthetics portfolio with the addition of Envy’s Dermalinfusion, a non-surgical, non-invasive skin resurfacing system for the face and body. Offered in physician’s offices, medical spas and luxury spas, Dermalinfusion is the only treatment that simultaneously exfoliates, extracts and infuses the skin with professional strength serums, using medical grade diamond treatment tips. Each serum is specifically formulated to help treat a variety of skin concerns across all skin types.

The acquisition of Envy Medical’s Dermalinfusion reinforces our commitment to skin care and to offering a full range of solutions for Allergan customers and consumers. The breakthrough technology for skin resurfacing appeals to millennials and their focus on skin quality and is a perfect opportunity for Allergan to help our healthcare providers capture new patients for this and other medical aesthetic procedures,

said Carrie Strom,
Senior Vice President,
U.S. Medical Aesthetics at Allergan.

As a leader in non-invasive medical aesthetic devices, we believe the Dermalinfusion system is a perfect fit with Allergan and its product portfolio. We have always looked to broaden awareness and reach of Dermalinfusion, and Allergan’s commitment to innovation, brand development, and global market expansion is perfectly aligned with our vision. We are very excited to join Allergan,

Envy Medical CEO Arash Khazei added.

In addition to Dermalinfusion systems and serums, Envy offers a complete line of proprietary, take-home skin care products promoting healthy skin. These products will further complement Allergan’s SkinMedica® portfolio of innovative skin care products.

GMP news
Pharmaceutical industry News and events. Technology transfer and contract manufacturing of medicines.